Skip to content
Annovis Bio logo

Annovis Bio (ANVS) Q1 2024 Earnings

ANVS·Reported May 13, 2024·Before market open

Diluted EPS came in at $-0.72, beat the $-0.87 consensus by $0.15.

Diluted EPS
$-0.72beat by $0.15
Consensus: $-0.87
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about Annovis Bio's Q1 2024 earnings report.

Annovis Bio (ANVS) reported Q1 2024 earnings on May 13, 2024 before market open.

Annovis Bio reported diluted EPS of $-0.72 for Q1 2024.

EPS beat the consensus estimate of $-0.87 by $0.15.

You can read the 10-Q periodic report (0001558370-24-007820) directly on SEC EDGAR. The filing index links above go to sec.gov.